Article
[Personalized medicine for epilepsy based on the pharmacogenomic testing].
Brain and nerve = Shinkei kenkyu no shinpo - 1 Apr 2011
Yoshida Shuichi, Sugawara Takayuki, Nishio Takuhiro, Kaneko Sunao
Abstract excerpt
Currently a trial-and-error approach is employed to determine the most effective antiepileptic drug (AED) and dosage for a patient, and almost 30% of all patients are resistant to AED therapy. Introduction of personalized medicine for epilepsy based on pharmacogenomic testing is a new avenue for optimizing AED therapy. However, several crucial issues remain to be resolved before this initiative can be fully...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
